Retractable Technologies (RVP) EPS (Basic) Growth (3y) (2013 - 2026)
Analysis
Retractable Technologies (RVP) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.44 Bn | 47.58 Bn | 2.32 Bn | 0.16% |
| 2 | Medline | 27.79 Bn | 25.12 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.38 Bn | 23.95 Bn | 329.20 Mn | 1.12% |
| 4 | Baxter International | 12.45 Bn | 10.30 Bn | 1.03 Bn | 33.97% |
| 5 | Stevanato Group S.p.A | 5.68 Bn | 5.57 Bn | 100.91 Mn | -11.46% |
| 6 | Acme United | 233.78 Mn | 228.74 Mn | 26.69 Mn | 10.94% |
| 7 | Rockwell Medical | 30.48 Mn | 5.68 Mn | 3.24 Mn | 43.11% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 39.35% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 23.50% |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.35% |
| Mar 31, 2026 | -87.49% |
| Dec 31, 2025 | 15.23% |
| Sep 30, 2025 | -59.85% |
| Jun 30, 2025 | 64.92% |
| Mar 31, 2025 | -52.58% |
| Dec 31, 2024 | -41.39% |
| Sep 30, 2024 | -32.89% |
| Jun 30, 2024 | -52.17% |
| Mar 31, 2024 | -71.33% |
| Dec 31, 2023 | -26.25% |
| Sep 30, 2023 | -34.20% |
| Jun 30, 2023 | -47.32% |
| Mar 31, 2023 | 89.93% |
| Dec 31, 2022 | -65.82% |
| Sep 30, 2022 | 83.95% |
| Jun 30, 2022 | -166.67% |
| Mar 31, 2022 | 197.38% |
| Dec 31, 2021 | 299.04% |
| Sep 30, 2021 | 203.91% |